| Target Price | $11.69 |
| Price | $3.75 |
| Potential |
211.80%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Inventiva - ADR 2027 .
The average Inventiva - ADR target price is $11.69.
This is
211.80%
register free of charge
$26.94
618.42%
register free of charge
$9.26
146.99%
register free of charge
|
|
| A rating was issued by 17 analysts: 16 Analysts recommend Inventiva - ADR to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Inventiva - ADR stock has an average upside potential 2027 of
211.80%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 5.14 | 6.48 |
| 51.33% | 26.03% | |
| EBITDA Margin | -2,894.94% | -1,934.45% |
| 189.80% | 33.11% | |
| Net Margin | -7,906.81% | -2,270.85% |
| 294.97% | 71.25% |
9 Analysts have issued a sales forecast Inventiva - ADR 2026 . The average Inventiva - ADR sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Inventiva - ADR EBITDA forecast 2026. The average Inventiva - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Inventiva - ADR Analysts have issued a net profit forecast 2026. The average Inventiva - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.18 | -0.76 |
| 38.42% | 64.98% | |
| P/E | negative | |
| EV/Sales | 113.26 |
11 Analysts have issued a Inventiva - ADR forecast for earnings per share. The average Inventiva - ADR EPS is
This results in the following potential growth metrics and future valuations:
Inventiva - ADR...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| KBC SECURITIES |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Jun 30 2026 |
| PORTZAMPARC BNP PARIBAS |
Locked
➜
Locked
|
Locked | Jun 28 2026 |
| PIPER SANDLER COMPANIES |
Locked
➜
Locked
|
Locked | Jun 23 2026 |
| GUGGENHEIM SECURITIES LLC |
Locked
➜
Locked
|
Locked | May 26 2026 |
| LIFESCI CAPITAL |
Locked
➜
Locked
|
Locked | Mar 30 2026 |
| LEERINK PARTNERS |
Locked
➜
Locked
|
Locked | Mar 30 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
KBC SECURITIES:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Jun 30 2026 |
|
Locked
PORTZAMPARC BNP PARIBAS:
Locked
➜
Locked
|
Jun 28 2026 |
|
Locked
PIPER SANDLER COMPANIES:
Locked
➜
Locked
|
Jun 23 2026 |
|
Locked
GUGGENHEIM SECURITIES LLC:
Locked
➜
Locked
|
May 26 2026 |
|
Locked
LIFESCI CAPITAL:
Locked
➜
Locked
|
Mar 30 2026 |
|
Locked
LEERINK PARTNERS:
Locked
➜
Locked
|
Mar 30 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


